ABOUT US
At Diaceutics we believe that every patient should have access to the right treatment at the right time to positively impact their disease outcome, and we are committed to solving commercialization challenges.
We provide the world's leading pharma and biotech companies with an end-to-end commercialization solution for the launch of precision medicine through our platform
DXRX - The Diagnostic Network®
Copyright © 2024, Diaceutics. All rights reserved
A real-world study showing how claims-only targeting misrepresents HCP relevance and how a clinically informed approach changes everything.
*Mandatory fields. For details on how we process your personal data, see Diaceutics Privacy Statement.
Why claims-only targeting is holding rare disease strategy back
Stop targeting based on what happened.
Start targeting based on what’s happening.
You’re looking in the wrong place. Claims data tells you who was active, not who is.
Claims ≠ Care.
Billing events don’t capture or reflect ongoing clinical responsibility.
The Invisible Work.
Most rare disease care happens outside of the claims system.
You’re investing in the wrong HCPs.
The misdirection.
Relevance is Misranked.
The right HCPs ranked in the wrong order.
Stop predicting the future with the past.
From Lagging to Leading.
Focus on who is actively managing patients today.
Redefine relevance.
Where opportunity lives.
Growth sits with HCPs still shaping decisions.